Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells

Molecular Cancer

Volumn 8, Issue , 2009, Pages

  Uchida, Daisuke ^a   Onoue, Tomitaro ^a   Begum, Nasima Mila ^a   Kuribayashi, Nobuyuki ^a   Tomizuka, Yoshifumi ^a   Tamatani, Tetsuya ^a   Nagai, Hirokazu ^a   Miyamoto, Youji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CISPLATIN; FLUOROURACIL; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 2; MESSENGER RNA; PIPERANOMETOZINE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CXCR4 PROTEIN, HUMAN; KLF2 PROTEIN, HUMAN; LUCIFERASE; QUINOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MOUSE; MOUTH CANCER; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REGULATORY SEQUENCE; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; DNA MICROARRAY; DOWN REGULATION; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; METABOLISM; MOUTH TUMOR; NUDE MOUSE; PATHOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR VOLUME;

MUS MUSCULUS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; CISPLATIN; DOWN-REGULATION; FLOW CYTOMETRY; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LUCIFERASES; MICE; MICE, INBRED BALB C; MICE, NUDE; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; QUINOLINES; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 70049106413     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-8-62     Document Type: Article

References (52)

1. Parkin DM Bray F Ferlay J Pisani P Estimating the world cancer burden: Globocan 2000 Int J Cancer 2001, 94:153-156. 10.1002/ijc.1440 11668491
2. Johnson JT Barnes EL Myers EN Schramm VL Jr Borochovitz D Sigler BA The extracapsular spread of tumors in cervical node metastasis Arch Otolaryngol 1981, 107:725-729. 7316852
3. Decroix Y Ghossein NA Experience of the Curie Institute in treatment of cancer of the mobile tongue: II. Management of the neck nodes Cancer 1981, 47:503-508. 10.1002/ 1097-0142(19810201)47:3<503::AID-CNCR2820470313>3.0.CO;2-1 7226002
4. Johnson JT Wagner RL Myers EN A long-term assessment of adjuvant chemotherapy on outcome of patients with extracapsular spread of cervical metastases from squamous carcinoma of the head and neck Cancer 1996, 77:181-185. 10.1002/ (SICI)1097-0142(19960101)77:1<181::AID-CNCR29>3.0.CO;2-0 8630927
5. Labadie RF Yarbrough WG Weissler MC Pillsbury HC Mukherji SK Nodal volume reduction after concurrent chemo- and radiotherapy: Correlation between initial CT and histopathologic findings Am J Neuroradiol 2000, 21:310-314. 10696014
6. Rossi D Zlotnik A The biology of chemokines and their receptors Annu Rev Immunol 2000, 18:217-242. 10.1146/annurev.immunol.18.1.217 10837058
7. Muller A Homey B Soto H Ge N Catron D Buchanan ME McClanahan T Murphy E Yuan W Wagner SN Barrera JL Mohar A Verástegui E Zlotnik A Involvement of chemokine receptors in breast cancer metastasis Nature 2001, 410:50-56. 10.1038/35065016 11242036
8. Scotton CJ Wilson JL Milliken D Stamp G Balkwill FR Epithelial cancer cell migration: A role for chemokine receptors? Cancer Res 2001, 61:4961-4965. 11431324
9. Taichman RS Cooper C Keller ET Pienta KJ Taichman NS McCauley LK Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone Cancer Res 2002, 62:1832-1837. 11912162
10. Schrader AJ Lechner O Templin M Dittmar KE Machtens S Mengel M Probst-Kepper M Franzke A Wollensak W Gatzlaff P Atzpodien J Buer J Lauber J CXCR4/CXCL12 expression and signalling in kidney cancer Br J Cancer 2002, 86:1250-1256. 10.1038/sj.bjc.6600221 11953881
11. Zhou Y Larsen PH Hao C Yong VW CXCR4 is a major chemokine receptor on glioma cells and mediates their survival J Biol Chem 2002, 277:49481-49487. 10.1074/jbc.M206222200 12388552
12. Kijima T Maulik G Ma PC Tibaldi EV Turner RE Rollins B Sattler M Johnson BE Salgia R Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells Cancer Res 2002, 62:6304-6311. 12414661
13. Uchida D Begum NM Ammar A Nakashiro K Kawamata H Tateishi Y Hamakawa H Yoshida H Sato M Possible role of stromal cell-derived factor-1/CXCR4 signaling on lymph-node metastasis of oral squamous cell carcinoma Exp Cell Res 2003, 290:289-302. 10.1016/S0014-4827(03)00344-6 14567988
14. Uchida D Begum NM Tomizuka Y Bando T Almofti A Yoshida H Sato M Acquisition of lymph node, but not distant metastatic potentials, by the over-expression of CXCR4 in human oral squamous cell carcinoma cells Lab Invest 2004, 84:1538-1546. 10.1038/labinvest.3700190 15492752
15. Ammar A Uchida D Begum NM Tomizuka Y Iga H Yoshida H Sato M The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma Int J Oncol 2004, 25:65-71. 15201990
16. Uchida D Onoue T Tomizuka Y Begum NM Miwa Y Yoshida H Sato M Involvement of an autocrine stromal cell-derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma Mol Cancer Res 2007, 5(7):685-694. 10.1158/1541-7786.MCR-06-0368 17634424
17. Bleul CC Farzan M Choe H Parolin C Clark-Lewis I Sodroski J Springer TA The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry Nature 1996, 382:829-833. 10.1038/382829a0 8752280
18. De Clercq E The bicyclam AMD3100 story Nat Rev Drug Discov 2003, 2:581-587. 10.1038/nrd1134 12815382
19. Murakami T Nakajima T Koyanagi Y Tachibana K Fujii N Tamamura H Yoshida N Waki M Matsumoto A Yoshie O Kishimoto T Yamamoto N Nagasawa T A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection J Exp Med 1997, 186:1389-1393. 10.1084/jem.186.8.1389 2199089 9334379
20. Baba M Nishimura O Kanzaki N Okamoto M Sawada H Iizawa Y Shiraishi M Aramaki Y Okonogi K Ogawa Y Meguro K Fujino M A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity Proc Nat Acad Sci USA 1999, 96:5698-5703. 10.1073/ pnas.96.10.5698 21923 10318947
21. Moore MA The role of chemoattraction in cancer metastases Bioessays 2001, 23:674-676. 10.1002/bies.1095 11494314
22. Kawamata H Nakashiro K Uchida D Hino S Omotehara F Yoshida H Sato M Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell Br J Cancer 1998, 77:71-78. 9459148
23. Sato M Harada K Bando T Shirakami T Nakashiro K Yoshida H Nakai S Kawai K Adachi M Characteristics of antitumor activity of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]- 2(1H)-quinolinone (vesnarinone) against a human adenoid squamous carcinoma-forming cell line grown in athymic nude mice Cancer Lett 1995, 91:1-9. 10.1016/0304-3835(95)03713-7 7750082
24. Kawamata H Nakashiro K Uchida D Hino S Harada K Yoshida H Sato M Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines Int J Cancer 1997, 70:120-127. 10.1002/ (SICI)1097-0215(19970106)70:1<120::AID-IJC18>3.0.CO;2-P 8985100
25. Guan XF Qiu WL He RG Zhou XJ Selection of adenoid cystic carcinoma cell clone highly metastatic to the lung: An experimental study Int J Oral Maxillofac Surg 1997, 26:116-119. 10.1016/S0901-5027(05)80830-6 9151166
26. Burns JM Summers BC Wang Y Melikian A Berahovich R Miao Z Penfold ME Sunshine MJ Littman DR Kuo CJ Wei K McMaster BE Wright K Howard MC Schall TJ A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development J Exp Med 2006, 203:2201-2213. 10.1084/jem.20052144 2118398 16940167
27. Asanoi H Sasayama S Iuchi K Kameyama T Acute hemodynamic effects of a new inotropic agent (OPC-8212) in patients with congestive heart failure J Am Coll Cardiol 1987, 9:865-871. 3558984
28. Cohn JN Goldstein SO Greenberg BH Lorell BH Bourge RC Jaski BE Gottlieb SO McGrew F 3rd DeMets DL White BG A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators N Engl J Med 1998, 339:1810-1816. 10.1056/NEJM199812173392503 9854116
29. Sato S Tomoyasu S Okabe-Kado J Hozumi M Tsuruoka N Nakai S Adachi M Honma Y Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent Exp Hematol 1996, 24:37-42. 8536790
30. Isaka K Fujito A Sagawa Y Yudate T Nishi H Ito H Takayama M Induction of apoptosis in human choriocarcinoma cell lines by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (vesnarinone) Oncol Rep 2002, 9:1299-1305. 12375038
31. Khalaf W Maina C Byers J Harvey W Interferon-alpha 2β and vesnarinone influence levels of tumor necrosis factor-alpha, apoptosis, or interleukin 6 in ESKOL, a hairy cell leukemic cell line. A potential cytokine and oncogene relationship regulating apoptosis is suggested Leuk Res 2002, 26:169-177. 10.1016/S0145-2126(01)00100-X 11755467
32. Sato M Harada K Yura Y Bando T Azuma M Kawamata H Iga H Yoshida H Induction of tumour differentiation and apoptosis and LeY antigen expression in treatment with differentiation-inducing agent, vesnarinone, of a patient with salivary adenoid cystic carcinoma Apoptosis 1997, 2:106-113. 14646560
33. Sato M Harada K Yura Y Azuma M Kawamata H Iga H Tsujimoto H Yoshida H Adachi M The treatment with differentiation- and apoptosis-inducing agent, vesnarinone, of a patient with oral squamous cell carcinoma Apoptosis 1997, 2:313-318. 10.1023/A:1026493205097 14646544
34. Patnaik A Rowinsky EK Tammara BK Hidalgo M Drengler RL Garner AM Siu LL Hammond LA Felton SA Mallikaarjun S Von Hoff DD Eckhardt SG Phase I and pharmacokinetic study of the differentiating agent vesnarinone in combination with gemcitabine in patients with advanced cancer J Clin Oncol 2000, 18:3974-3985. 11099327
35. Omotehara F Kawamata H Uchida D Hino S Nakashiro K Fujimori T Vesnarinone, a differentiation inducing drug, directly activates p21(waf1) gene promoter via Sp1 sites in a human salivary gland cancer cell line Br J Cancer 2002, 87:1042-1046. 10.1038/sj.bjc.6600592 12434298
36. Moriuchi M Moriuchi H Margolis DM Fauci AS USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry J Immunol 1999, 162:5986-5992. 10229837
37. Helbig G Christopherson KW 2nd Bhat-Nakshatri P Kumar S Kishimoto H Miller KD Broxmeyer HE Nakshatri H NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4 J Biol Chem 2003, 278:21631-21638. 10.1074/jbc.M300609200 12690099
38. Staller P Sulitkova J Lisztwan J Moch H Oakeley EJ Krek W Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL Nature 2003, 425:307-311. 10.1038/nature01874 13679920
39. Petit I Szyper-Kravitz M Nagler A Lahav M Peled A Habler L Ponomaryov T Taichman RS Arenzana-Seisdedos F Fujii N Sandbank J Zipori D Lapidot T G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4 Nat Immunol 2002, 3:687-694. 10.1038/ni813 12068293
40. Katayama A Ogino T Bandoh N Nonaka S Harabuchi Y Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma Clin Cancer Res 2005, 11:2937-2946. 10.1158/ 1078-0432.CCR-04-1470 15837745
41. Kulbe H Hagemann T Szlosarek PW Balkwill FR Wilson JL The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells Cancer Res 2005, 65:10355-10362. 10.1158/0008-5472.CAN-05-0957 16288025
42. Manna SK Aggarwal BB Vesnarinone suppresses TNF-induced activation of NF-kappa B, c-Jun kinase, and apoptosis J Immunol 2000, 164:5815-5825. 10820260
43. Anderson KP Kern CB Crable SC Lingrel JB Isolation of a gene encoding a functional zinc finger protein homologous to erythroid Krüppel-like factor: Identification of a new multigene family Mol Cell Biol 1995, 15:5957-5965. 230847 7565748
44. Buckley AF Kuo CT Leiden JM Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway Nat Immunol 2001, 2:698-704. 10.1038/90633 11477405
45. Banerjee SS Feinberg MW Watanabe M Gray S Haspel RL Denkinger DJ Kawahara R Hauner H Jain MK The Krüppel-like factor KLF2 inhibits peroxisome proliferator-activated receptor-gamma expression and adipogenesis J Biol Chem 2003, 278:2581-2584. 10.1074/jbc.M210859200 12426306
46. SenBanerjee S Lin Z Atkins GB Greif DM Rao RM Kumar A Feinberg MW Chen Z Simon DI Luscinskas FW Michel TM Gimbrone MA Jr García-Cardeña G Jain MK KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation J Exp Med 2004, 199:1305-1315. 10.1084/jem.20031132 2211816 15136591
47. Wu J Lingrel JB KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1 Oncogene 2004, 23:8088-8096. 10.1038/sj.onc.1207996 15361832
48. Wang F Zhu Y Huang Y McAvoy S Johnson WB Cheung TH Chung TK Lo KW Yim SF Yu MM Ngan HY Wong YF Transcriptional repression of WEE1 by Krüppel-like factor 2 is involved in DNA damage-induced apoptosis Oncogene 2005, 24:3875-3885. 10.1038/sj.onc.1208546 15735666
49. Wick MJ Blaine S Van Putten V Saavedra M Nemenoff RA Lung Krüppel-like factor (LKLF) is a transcriptional activator of the cytosolic phospholipase A2 alpha promoter Biochem J 2005, 387:239-246. 10.1042/BJ20041458 1134952 15540987
50. Bhattacharya R Senbanerjee S Lin Z Mir S Hamik A Wang P Mukherjee P Mukhopadhyay D Jain MK Inhibition of vascular permeability factor/ vascular endothelial growth factor-mediated angiogenesis by the Krüppel-like factor KLF2 J Biol Chem 2005, 280:28848-28851. 10.1074/ jbc.C500200200 15980434
51. Lomberk G Urrutia R The family feud: Turning off Sp1 by Sp1-like KLF proteins Biochem J 2005, 392:1-11. 10.1042/BJ20051234 1317658 16266294
52. Maruyama I Maruyama Y Nakajima T Kitajima I Osame M Zhao JQ Chen IS Nakai S Ikeda M Yabu-uchi Y Adachi M Vesnarinone inhibits production of HIV-1 in cultured cells Biochem Biophys Res Commun 1993, 195:1264-1271. 10.1006/bbrc.1993.2180 8216257